# Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

> **NCT00117702** · PHASE2,PHASE3 · TERMINATED · sponsor: **Technische Universität Dresden** · enrollment: 24 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **DRUG:** Tacrolimus
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT00117702
- **Lead sponsor:** Technische Universität Dresden
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-10
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 24 (ACTUAL)
- **Why stopped:** safety reasons
- **Last updated:** 2009-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00117702

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00117702, "Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00117702. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*